Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Day

Showing results (391-400 of 501) with videos related to

Pageof 51
Sort By:
Trials|July 27, 2023
Correction: OPAL: a randomised, placebo-controlled trial of opioid analgesia for the reduction of pain severity in people with acute spinal pain-a statistical analysis planCaitlin M P Jones, Chung-Wei Christine Lin, Richard O Day, et al.
British Journal of Clinical Pharmacology|April 20, 2004
Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjectsXuemin Jiang, Kenneth M Williams, Winston S Liauw, et al.
JMIR Mhealth and Uhealth|October 17, 2018
mHealth App Patient Testing and Review of Educational Materials Designed for Self-Management of Gout Patients: Descriptive Qualitative StudiesAmy D Nguyen, Lauren J Frensham, Michael Xc Wong, et al.
Lancet (London, England)|November 13, 2007
Assessment of diclofenac or spinal manipulative therapy, or both, in addition to recommended first-line treatment for acute low back pain: a randomised controlled trialMark J Hancock, Chris G Maher, Jane Latimer, et al.
The Journal of Rheumatology. Supplement|July 1, 1982
Auranofin in rheumatoid arthritisG D Champion, D Bieri, C D Browne, et al.
The Journal of Rheumatology|May 22, 2001
Patient based method of assessing adverse events in clinical trials in rheumatology: the revised Stanford Toxicity IndexV Welch, G Singh, V Strand, et al.
Inflammopharmacology|January 1, 1997
Osteoarthritis antirheumatic drug trials: effects of a standardized instructional videotape on the reliability of observer-dependent dependent outcome measuresN Bellamy, C Bachmeier, P M Brooks, et al.
Journal of Inflammation Research|April 1, 2021
BT2 Suppresses Human Monocytic-Endothelial Cell Adhesion, Bone Erosion and InflammationMei-Chun Yeh, Ben J Wu, Yue Li, et al.
The Medical Journal of Australia|July 17, 2012
Towards the delivery of appropriate health care in AustraliaWilliam B Runciman, Enrico W Coiera, Richard O Day, et al.
The Lancet. Rheumatology|January 17, 2024
Is it ethical to prescribe paracetamol for acute low back pain and osteoarthritis?Richard O Day, Milton Cohen, Matthew J Coleshill, et al.
Pageof 51

Showing results (391-400 of 501) with videos related to

Sort By:
Pageof 51
Trials|July 27, 2023
Correction: OPAL: a randomised, placebo-controlled trial of opioid analgesia for the reduction of pain severity in people with acute spinal pain-a statistical analysis planCaitlin M P Jones, Chung-Wei Christine Lin, Richard O Day, et al.
British Journal of Clinical Pharmacology|April 20, 2004
Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjectsXuemin Jiang, Kenneth M Williams, Winston S Liauw, et al.
JMIR Mhealth and Uhealth|October 17, 2018
mHealth App Patient Testing and Review of Educational Materials Designed for Self-Management of Gout Patients: Descriptive Qualitative StudiesAmy D Nguyen, Lauren J Frensham, Michael Xc Wong, et al.
Lancet (London, England)|November 13, 2007
Assessment of diclofenac or spinal manipulative therapy, or both, in addition to recommended first-line treatment for acute low back pain: a randomised controlled trialMark J Hancock, Chris G Maher, Jane Latimer, et al.
The Journal of Rheumatology. Supplement|July 1, 1982
Auranofin in rheumatoid arthritisG D Champion, D Bieri, C D Browne, et al.
The Journal of Rheumatology|May 22, 2001
Patient based method of assessing adverse events in clinical trials in rheumatology: the revised Stanford Toxicity IndexV Welch, G Singh, V Strand, et al.
Inflammopharmacology|January 1, 1997
Osteoarthritis antirheumatic drug trials: effects of a standardized instructional videotape on the reliability of observer-dependent dependent outcome measuresN Bellamy, C Bachmeier, P M Brooks, et al.
Journal of Inflammation Research|April 1, 2021
BT2 Suppresses Human Monocytic-Endothelial Cell Adhesion, Bone Erosion and InflammationMei-Chun Yeh, Ben J Wu, Yue Li, et al.
The Medical Journal of Australia|July 17, 2012
Towards the delivery of appropriate health care in AustraliaWilliam B Runciman, Enrico W Coiera, Richard O Day, et al.
The Lancet. Rheumatology|January 17, 2024
Is it ethical to prescribe paracetamol for acute low back pain and osteoarthritis?Richard O Day, Milton Cohen, Matthew J Coleshill, et al.
Pageof 51